The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is dedicated to improving human health through the integration of the physical and biological sciences. The research agenda of the NIBIB will dramatically advance the Nation’s health by improving the detection, management, understanding, and ultimately, the prevention of disease.
Created December 29, 2000, the NIBIB is part of the National Institutes of Health (NIH), within the Department of Health and Human Services; the Federal government’s premier biomedical research agency. NIBIB-supported research brings advances in fields ranging from physics to nanotechnology to bear on the challenges of diagnosing, preventing and treating disease. Ultimately, the NIBIB seeks to translate research findings from the laboratory to the patient to improve quality of life and reduce the burden of disease. Health care and technology have long been linked in the United States. Today, cardiac pacemakers, mammograms, sustained-release medications, and artificial hips are but a few examples of how biomedical imaging and bioengineering are transforming health care.
- Ways to treat medical problems based on an individual’s genetic makeup.
- Light-based tools used in medicine and surgery that provide new ways to study, diagnose, and treat medical problems.
- Smart sensors that use chemical and physiological signals from the body to release drugs at the right dose in the right place at the right time.
- New imaging technologies and improvements in existing technologies to improve the diagnosis and treatment of many diseases.
- Drug delivery devices such as microneedles to painlessly deliver drugs and implantable devices that release drugs as needed.
- Tissue engineering research to promote the growth of skin on burn victims, restore vision in damaged eyes, and generate new organs for transplant.